scholarly journals Effects of Intramuscular Electrical Stimulation Using Inversely Placed Electrodes on Myofascial Pain Syndrome in the Shoulder: A Case Series

2016 ◽  
Vol 29 (2) ◽  
pp. 136 ◽  
Author(s):  
Sukumar Shanmugam ◽  
Lawrence Mathias ◽  
Ajay Thakur ◽  
Dhanesh Kumar
2021 ◽  
Vol 29 (1) ◽  
Author(s):  
Monavar Hadizadeh ◽  
Abbas Rahimi ◽  
Mohammad Javaherian ◽  
Meysam Velayati ◽  
Jan Dommerholt

Abstract Introduction Myofascial pain syndrome (MPS) is one of the most common disorders causing chronic muscle pain. Almost one-third of patients with musculoskeletal complaints meet the MPS criteria. The aim of this study is to evaluate the effectiveness of intramuscular electrical stimulation (IMES) in patients with MPS through a systematic review method. Methods PubMed, Scopus, Embase, ProQuest, PEDro, Web of Science, and CINAHL were systematically searched to find out the eligible articles without language limitations from 1990 to December 30, 2020. All relevant randomized controlled trials that compared the effectiveness of IMES with sham-IMES, dry needling, or exercise therapy in patients with MPS were included. Full texts of the selected studies were critically appraised using Revised Cochrane risk-of-bias tool for randomized trials (RoB2). Results Six studies (out of 397) had met our inclusion criteria (involving 158 patients) and were entered to the systematic review. Outcome measures examined in these studies included pain, range of motion, pressure pain threshold, biochemical factors, disability, and amount of analgesic use. In the most studies, it has been shown that IMES is more effective than the control group in improving some outcome measurements such as pain. Conclusion There is preliminary evidence from a few small trials suggesting the efficacy of IMES for the care of myofascial pain syndrome. The data support the conduct of larger trials investigating the efficacy of IMES.


2019 ◽  
pp. 91-97
Author(s):  
Niraj G

Background: Chronic abdominal wall pain (CAWP) is often undiagnosed and results in significant health care use as well as patient suffering. There are two main types: abdominal myofascial pain syndrome (AMPS) and anterior cutaneous nerve entrapment syndrome (ACNES). Although the 2 conditions share clinical similarities, they have subtly distinct unique features. Objectives: To highlight the current practice, elucidate the characteristics of the 2 types of CAWP, and direct the spotlight on abdominal myofascial pain. Study Design: Prospective case series. Setting: Tertiary pain medicine clinic in a university hospital. Methods: As a part of a prospective audit of management of chronic abdominal pain, patients completed brief pain inventory-short form questionnaires at baseline and at 3 months posttrigger point treatment. Results: All 3 patients were misdiagnosed with ACNES. Patient 1 was attending the emergency department once every 5 days prior to being correctly diagnosed with AMPS. Following trigger point treatment, there was a significant reduction in emergency department attendance. Patient 2, with a 10-year history of lower abdominal pain that resulted in severe disability, was able to mobilize following trigger point treatment. Patient 3, with a high opioid use (360 mg per day), was able to discontinue opioids following ultrasound-guided trigger point injection with depot steroids. Limitations: Open label case series in a small cohort. Conclusions: AMPS is as common as the various visceral inflammatory diseases. Lack of awareness, ignoring its existence, and misdiagnosing it may not benefit patients with chronic abdominal pain. Key words: Chronic abdominal wall pain, abdominal myofascial pain syndrome, anterior cutaneous nerve entrapment syndrome, viscerosomatic convergence


2021 ◽  
Author(s):  
Jaldhi Patel ◽  
Saba Javed

SARS-CoV-2 is a novel virus that has caused a plethora of dysfunctions and changes in the human body. Our goal in this case study series was to demonstrate the relationship that coronavirus has had in newly diagnosing patients with myofascial pain syndrome (MFPS). Medical records were obtained from a pain clinic that demonstrated the effects of this virus on patients who developed MFPS between March 2020 and December 2020. Chart reviews were performed and demonstrated patients who had a history of chronic pain had subsequent episodes of worsening exacerbations of pain, more specifically trigger points, after being diagnosed with coronavirus. MFPS and SARS-CoV-2 are proposed to be correlated amongst chronic pain patients. Potential pathological mechanisms include coronavirus-induced hypoxic muscle dysfunctions as well as psychological stress triggering pain receptors, leading to myofascial pain syndrome.


2018 ◽  
pp. 103-110
Author(s):  
Gopinarth Niraj

Background: Trigger point injection is the current standard in the management of abdominal myofascial pain syndrome (AMPS). However, multiple trigger point injections can cause significant discomfort and there is a possibility of missing trigger points resulting in a reduced efficacy of trigger point treatment. Recently, abdominal wall blocks have been reported in the management of chronic abdominal wall pain. Transmuscular quadratus lumborum block (TQLB) is a novel abdominal wall block. Objective: The report describes the role of the ultrasound-guided TQLB with depot steroids in the management of AMPS. Study Design: Prospective case series. Setting: Tertiary pain medicine clinic in a University Hospital. Methods: Adult patients with AMPS under the care of a single physician were offered TQLBs with a mixture of local anaesthetic and depot methylprednisolone instead of multiple trigger point injections as a part of an on-going prospective longitudinal audit into the management of AMPS. Patients completed brief pain inventory questionnaire at baseline and at 12 weeks postprocedure. Results: Thirty patients underwent TQLB. All patients reported complete absence of pain within 15 minutes of the block and sensory testing revealed extensive hypoaesthesia extending from thoracic T6 to T12 anteriorly. Clinically significant benefit at 12 weeks was reported by 36% of patients, with 60% (18/30) of the patients preferring to receive the novel intervention instead of multiple trigger point injections. None of the patients reported post-procedural flare up. Limitations: Open label case series in a small cohort. Conclusion: The prospective series in a limited cohort suggests that TQLB with depot steroids could play a role in the management of AMPS. Key words: Abdominal myofascial pain syndrome, transmuscular quadratus lumborum block, trigger point treatment, nonspecific abdominal pain, viscerosomatic convergence


Sign in / Sign up

Export Citation Format

Share Document